The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19 AH Mansourabadi, M Sadeghalvad, HR Mohammadi-Motlagh, N Rezaei Life sciences 258, 118185, 2020 | 86 | 2020 |
Influenza vaccine: Where are we and where do we go? M Keshavarz, H Mirzaei, M Salemi, F Momeni, MJ Mousavi, ... Reviews in medical virology 29 (1), e2014, 2019 | 85 | 2019 |
Immune microenvironment in different molecular subtypes of ductal breast carcinoma M Sadeghalvad, HR Mohammadi‐Motlagh, N Rezaei Breast cancer research and treatment, 2020 | 44 | 2020 |
Soybean Bowman-Birk protease inhibitor (BBI): Identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29 A Fereidunian, M Sadeghalvad, MO Oscoie, A Mostafaie Archives of medical research 45 (6), 455-461, 2014 | 36 | 2014 |
Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies M Sadeghalvad, AH Mansourabadi, ... Reviews in Medical Virology, 2022 | 31 | 2022 |
An inflammatory triangle in Sarcoidosis: PPAR-γ, Immune microenvironment, and Inflammation P Jabbari, M Sadeghalvad, N Rezaei. Expert Opinion on Biological Therapy, 2021 | 21 | 2021 |
In vivo anti‐inflammatory efficacy of the combined Bowman‐Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean M Sadeghalvad, HR Mohammadi‐Motlagh, AG Karaji, A Mostafaie Journal of biochemical and molecular toxicology 33 (12), e22406, 2019 | 18 | 2019 |
Introduction on Monoclonal Antibodies M Sadeghalvad, N Rezaei Monoclonal Antibody, 2021 | 15 | 2021 |
Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis M Balibeglooa, SA Nejadghaderia, M Sadeghalvad, A Soleymanitabar, ... International Immunopharmacology 96, 2021 | 15 | 2021 |
The effect of CYP2C9* 2, CYP2C9* 3, and VKORC1-1639 G> A polymorphism in patients under warfarin therapy in city of Kermanshah Z Hosseinkhani, M Sadeghalvad, F Norooznezhad, R Khodarahmi, ... Research in pharmaceutical sciences 13 (4), 377-384, 2018 | 14 | 2018 |
Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells M Sadeghalvad, K Mansouri, HR Mohammadi-Motlagh, F Noorbakhsh, ... Revista da Associação Médica Brasileira 68, 456-462, 2022 | 10 | 2022 |
Serological and Molecular Tests for COVID-19: a recent update AH Mansourabadi, M Sadeghalvad, HR Mohammadi-Motlagh, AA Amirzargar. Iranian Journal of Immunology 18 (1), 13-33, 2021 | 10 | 2021 |
Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? N Omidian, P Mohammadi, M Sadeghalvad, HR Mohammadi-Motlagh Biomedicine & Pharmacotherapy, 113534, 2022 | 8 | 2022 |
Novel G6PC3 mutations in patients with congenital neutropenia: case reports and review of the literature SF Maroufi, Z Shaka, H Mojtabavi, M Sadeghalvad, E Rayzan, I Sedighi, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 6 | 2021 |
Toll Like Receptors M Sadeghalvad, HR Mohammadi‐Motlagh, N Rezaei Encyclopedia of Infection and Immunity, 2021 | 6 | 2021 |
β cell and autophagy: What do we know? HR Mohammadi-Motlagh, M Sadeghalvad, N Yavari, R Primavera, ... Biomolecules 13 (4), 649, 2023 | 5 | 2023 |
2-Methylpyridine-1-ium-1-sulfonate as an Inducer of Apoptosis and Cell Cycle Arrest: A comparative in vitro and Computational Study HR Mohammadi-Motlagh, R Yarani, M Sadeghalvad, E Adham, H Rasouli, ... Nutrition and cancer 71 (4), 643-656, 2019 | 4 | 2019 |
Evaluation of Beclin-1 and Atg5 genes expression levels in peripheral blood cells of patients with rheumatoid arthritis B Kardideh, M Sadeghalvad, Z Samimi, HR Mohammadi Motlagh, ... Feyz Medical Sciences Journal 23 (2), 135-142, 2019 | 4 | 2019 |
Structure and Function of the Immune System M Sadeghalvad, HR Mohammadi-Motlagh, N Rezaei Elsevier, 2022 | 3 | 2022 |
Organs and Tissues of the Immune System HR Mohammadi-Motlagh, M Sadeghalvad, Rezaei,Nima Encyclopedia of Infection and Immunity, 2021 | 3 | 2021 |